Cite
HARVARD Citation
Zhao, Y. et al. (n.d.). 104P Camrelizumab combined with chemotherapy and apatinib as first-line therapy for extensive-stage small cell lung cancer: A phase II single-arm, exploratory research. Immuno-oncology technology. p. . [Online].